Literature DB >> 17511679

Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways.

M Bouchentouf1, B F Benabdallah, J Rousseau, L M Schwartz, J P Tremblay.   

Abstract

Seventy-five percent of the myoblasts transplanted in the mouse muscle die during the first 4 days following transplantation. The purpose of this study was to determine if anoikis plays a role in this phenomenon. Survival and proliferation of myoblasts in vitro were determined by Hoescht-PI labeling and cell counts respectively. In vivo cell survival and proliferation were quantified by injecting human male myoblasts labeled with (14)C-thymidine in SCID mouse muscles. Survival and proliferation of the transplanted myoblasts were evaluated by scintigraphy and quantitative PCR of human Y chromosomal DNA. Inclusion of the extracellular matrix protein fibronectin enhanced transplanted myoblast survival by 1.7-fold while vitronectin improved their proliferation by 1.8-fold. Reductions in FADD and Bit1 expression reduced anoikis in vitro and improved the injected myoblast survival in vivo. Ectopic expression of the anti-apoptotic protein Bcl-2 completely abolished myoblast anoikis in vitro and enhanced cell survival by 3.1-fold in vivo. Cell death following transplantation appears to me mediated in part by anoikis. Inclusion of extracellular matrix proteins enhanced both survival and proliferation. Reduced expression of the proapoptotic proteins Bit1 and FADD or overexpression of Bcl-2 improved myoblast survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17511679     DOI: 10.1111/j.1600-6143.2007.01830.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  17 in total

Review 1.  Death and inflammation following somatic cell transplantation.

Authors:  Ian B Copland; Jacques Galipeau
Journal:  Semin Immunopathol       Date:  2011-05-01       Impact factor: 9.623

2.  In vivo fluorescence imaging of muscle cell regeneration by transplanted EGFP-labeled myoblasts.

Authors:  Xiaoyin Xu; Zhong Yang; Qiang Liu; Yaming Wang
Journal:  Mol Ther       Date:  2010-02-02       Impact factor: 11.454

3.  Timed Delivery of Therapy Enhances Functional Muscle Regeneration.

Authors:  Christine A Cezar; Praveen Arany; Sarah A Vermillion; Bo Ri Seo; Herman H Vandenburgh; David J Mooney
Journal:  Adv Healthc Mater       Date:  2017-07-13       Impact factor: 9.933

4.  Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy.

Authors:  Sébastien Goudenege; Yann Lamarre; Nicolas Dumont; Joël Rousseau; Jérôme Frenette; Daniel Skuk; Jacques P Tremblay
Journal:  Mol Ther       Date:  2010-08-03       Impact factor: 11.454

Review 5.  Stem cell therapy for muscular dystrophies.

Authors:  Stefano Biressi; Antonio Filareto; Thomas A Rando
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

6.  Implications of Bit1 and AIF overexpressions in esophageal squamous cell carcinoma.

Authors:  Tianli Fan; Fang Tian; Shanyong Yi; Yang Ke; Shengna Han; Lirong Zhang; Hongtao Liu
Journal:  Tumour Biol       Date:  2013-08-17

Review 7.  Biomaterial-based delivery for skeletal muscle repair.

Authors:  Christine A Cezar; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2014-09-28       Impact factor: 15.470

8.  Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells.

Authors:  Suk Ho Bhang; Seahyoung Lee; Tae-Jin Lee; Wan-Geun La; Hee-Seok Yang; Seung-Woo Cho; Byung-Soo Kim
Journal:  Tissue Eng Part A       Date:  2011-10-19       Impact factor: 3.845

9.  Bit-1 is an essential regulator of myogenic differentiation.

Authors:  Genevieve S Griffiths; Jinger Doe; Mayumi Jijiwa; Pam Van Ry; Vivian Cruz; Michelle de la Vega; Joe W Ramos; Dean J Burkin; Michelle L Matter
Journal:  J Cell Sci       Date:  2015-03-13       Impact factor: 5.285

10.  Protein kinase D is a positive regulator of Bit1 apoptotic function.

Authors:  Hector Biliran; Yiwen Jan; Renwei Chen; Elena B Pasquale; Erkki Ruoslahti
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.